Oncotype DX Breast Cancer recurrence score resists inter-assay reproducibility with RT2-Profiler Multiplex RT-PCR
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncotype DX Breast Cancer recurrence score resists inter-assay reproducibility with RT2-Profiler Multiplex RT-PCR
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-30
DOI
10.1038/s41598-019-56910-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer
- (2018) Ivana Sestak et al. JAMA Oncology
- Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score
- (2018) Parker C. Wilson et al. Breast Journal
- Gene-expression Profiling – A Decision Impact Analysis: Decision Dependency on Oncotype DX® as a Function of Oncological Work Experience in 117 Cases
- (2018) CHRISTIAN EICHLER et al. ANTICANCER RESEARCH
- Human Bocavirus Infection of Permanent Cells Differentiated to Air-Liquid Interface Cultures Activates Transcription of Pathways Involved in Tumorigenesis
- (2018) Verena Schildgen et al. Cancers
- Making sense of replications
- (2017) Brian A Nosek et al. eLife
- MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer
- (2017) Andreas Bösl et al. PLoS One
- Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
- (2016) R. Gyanchandani et al. CLINICAL CANCER RESEARCH
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- Comprehensive Histologic Scoring to Maximize the Predictability of Pathology-generated Equation of Breast Cancer Oncotype DX Recurrence Score
- (2016) Thaer Khoury et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
- (2015) Michael D. Alvarado et al. ADVANCES IN THERAPY
- Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
- (2014) Torsten Nielsen et al. BMC CANCER
- An open investigation of the reproducibility of cancer biology research
- (2014) Timothy M Errington et al. eLife
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- A simple and reproducible breast cancer prognostic test
- (2013) Luigi Marchionni et al. BMC GENOMICS
- Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility
- (2013) P. Sinn et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
- (2012) Ralf Kronenwett et al. BMC CANCER
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
- (2011) Chungyeul Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals
- (2011) Vanessa Ditt et al. PLoS One
- Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
- (2010) Frederick L. Baehner et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
- (2008) Sunil S. Badve et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now